Study suggests possible link between artificial sweeteners and heart disease

Medical Xpress

writer

Medical Xpress

Medical Xpress

 

A study of more than 100 000 French adults published by The BMJ suggests an association between artificial sweeteners and increased cardiovascular disease risk, including heart attack and stroke.

Artificial sweeteners are present in thousands of food and beverage brands worldwide, however they remain a controversial topic and are currently being re-evaluated by the European Food Safety Authority, the World Health Organization, and other health agencies.

A team of researchers from the French National Institute for Health and Medical Research (Inserm) and colleagues conducted the large scale prospective cohort study with findings suggesting a potential direct association between higher artificial sweetener consumption (especially aspartame, acesulfame potassium, and sucralose) and increased cardiovascular disease risk.

Read more at Medical Xpress

More information: Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort, The BMJ (2022). DOI: 10.1136/bmj-2022-071204

Journal information: British Medical Journal (BMJ)

 

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Scientia Prof Kaarin Anstey

Scientia Prof Kaarin Anstey

New Brain Health Guidelines – What GPs Can Do

Expert panel – Dr Georgia Rigas & Dr Nadia Tejani, facilitated by Dr Angela Kwong

Expert panel – Dr Georgia Rigas & Dr Nadia Tejani, facilitated by Dr Angela Kwong

Navigating Perimenopause and Menopause – Managing Weight, Health and Wellbeing in General Practice

A/Prof Daryl Efron

A/Prof Daryl Efron

Autism & Mental Health Comorbidities

Dr Rebecca Purvis

Dr Rebecca Purvis

Pharmacogenomics in General Practice

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.